FDA Officials Speak Out: New Approvals & Safety Concerns Discussed
Patients on Dialysis Taking Denosumab May Be at Risk of Severe Hypocalcemia
CORRONA: History & Lessons Learned
ACR-FDA Summit Focuses on Study Design, Safety Considerations
The Great Debate: Belimumab vs. Voclosporin in Lupus Nephritis
FDA Discussed 2021 Drug Warnings & Approvals at ACR Annual Meeting
Trial Pits Upadacitinib vs. Adalimumab for Psoriatic Arthritis
Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care
FDA Requires New Boxed Warnings on JAK Inhibitors, Places Restrictions on Use
- 1
- 2
- 3
- …
- 19
- Next Page »